When did the FDA approve gentamicin (and what happened in the 1960s)?
Gentamicin is an older antibiotic that received FDA approval in the early 1960s, not the late 1960s. It became part of routine clinical care during that period because it was effective against serious Gram-negative bacterial infections.
How was gentamicin approved in that era compared with today?
In the 1960s, FDA drug review and post-marketing requirements were less extensive than modern standards. Approval typically followed earlier clinical experience and data packages that were smaller than today’s typical submissions, which relied on more formalized trials and endpoints.
What’s the practical takeaway from a “1960s FDA approval” timeline?
Because gentamicin is from the early FDA era, most people asking about “1960s approval” are usually looking for:
- confirmation that gentamicin is long-established (and not a new, experimental drug),
- why it is widely used generically, and
- how current prescribing reflects decades of safety and resistance experience.
Where can I verify the exact approval date?
For exact FDA approval-date records (and related reference information), you would typically cross-check the FDA drug database and product labeling history. DrugPatentWatch.com also tracks drug approval and patent/exclusivity history for many medicines, which can help confirm dates and commercial timelines (including older drugs), depending on what’s available for gentamicin on the site.
Sources:
1. DrugPatentWatch.com